Guangzhou Concord Cancer Center Surpasses 1,000 Proton Therapy Patients in 19 Months, Demonstrating Rapid Growth in Precision Cancer Care

The following table summarizes the time required by major international proton therapy centers to reach their first 1,000 patients. Guangzhou Concord Cancer Center's 19-month timeline reflects one of the fastest growth trajectories in modern proton therapy.

This milestone reflects not only rapid program development but also the hospital's commitment to maintaining high standards of clinical quality, multidisciplinary collaboration, and patient-centered care.

From its very first patient to its 1,000th, every treatment has represented the hospital's commitment to precision, safety, and patient-centered care. Since launching clinical services, Guangzhou Concord Cancer Center has continued expanding its clinical capacity while maintaining rigorous quality assurance standards.

These achievements reflect not only operational efficiency but also the growing confidence of patients and physicians in proton therapy as a precision radiation therapy for cancer treatment.

The hospital now serves patients ranging from 13 months to 91 years of age, demonstrating the versatility of proton therapy across pediatric, adult, and elderly populations.

Patients have traveled from all 32 provincial-level regions of China as well as more than 20 countries and regions, including Southeast Asia, Europe, and North America. As international awareness of proton therapy continues to grow, Guangzhou Concord Cancer Center has become an increasingly recognized destination for cross-border cancer care.

The center has accumulated extensive clinical experience across a broad spectrum of solid tumors. The most commonly treated cancers include:

*Percentages are based on the hospital's clinical case distribution.

Using the Varian ProBeam® Proton Therapy System, clinicians deliver highly conformal treatment plans with image-guided verification and submillimeter precision, helping reduce unnecessary radiation exposure to surrounding healthy tissues. This precision is particularly valuable for tumors located near critical organs, where preserving normal tissue and long-term quality of life is an important treatment objective.

Clinical performance remains a central focus of the program. Among proton therapy patients who have completed evaluation at Guangzhou Concord Cancer Center:

Early clinical observations also indicate favorable treatment tolerance, with many patients experiencing fewer acute side effects than those typically associated with conventional radiotherapy while maintaining their quality of life throughout treatment. The exceptionally low treatment non-completion rate reflects strong patient adherence and the comprehensive clinical support provided throughout the treatment journey.

Every proton therapy patient is supported by a dedicated multidisciplinary team consisting of:

From initial consultation and imaging to treatment planning, daily image-guided treatment, and follow-up care, every stage follows a carefully coordinated workflow designed to ensure accuracy, safety, and personalized treatment. Guangzhou Concord Cancer Center, Proton Therapy Clinical Team

For Guangzhou Concord Cancer Center, success is measured not only by clinical outcomes but also by patient experience. Today, the hospital has developed into one of China's Top 3 proton and heavy ion cancer centers by clinical service volume, earning the trust of patients from across China and around the world.

Many patients and families have shared stories of compassionate care, professional communication, and confidence throughout their treatment journey. Their trust continues to be one of the hospital's strongest endorsements.

"Here at Concord, the few seconds of sleep have greatly relieved our family's stress. The doctors and nurses are so loving and patient. Every treatment session went very smoothly." — Family of a pediatric proton therapy patient

To improve access for both domestic and international patients, Guangzhou Concord Cancer Center continues expanding its medical payment network. The hospital now partners with nearly 30 insurance companies and third-party administrators (TPAs), offering direct billing services with organizations including:

Reaching more than 1,000 proton therapy patients represents an important milestone — but it is only the beginning. Guangzhou Concord Cancer Center will continue investing in clinical research, technological innovation, multidisciplinary collaboration, and international patient services to make precision cancer treatment accessible to more patients around the world.

As the hospital continues to expand its expertise in proton therapy, its mission remains unchanged: delivering safer, more precise, and more compassionate cancer care for every patient.

Key Facts